首页> 美国卫生研究院文献>Cancer Science >Chemoprevention of 712‐Dimethylbenzaanthracene‐induced Mammary Carcinogenesis in Rat by the Combined Actions of Selenium Magnesium Ascorbic Acid and Retinyl Acetate
【2h】

Chemoprevention of 712‐Dimethylbenzaanthracene‐induced Mammary Carcinogenesis in Rat by the Combined Actions of Selenium Magnesium Ascorbic Acid and Retinyl Acetate

机译:硒镁抗坏血酸和乙酸视黄酯的联合作用化学预防712-二甲基苯并a蒽诱导的大鼠乳腺癌的发生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The chemopreventive actions of sodium selenite (SS), magnesium chloride (MC), ascorbic acid (AA) and retinyl acetate (RA), given singly or in combinations, on mammary carcinogenesis induced by 30 mg of 7,12‐dimethylbenz[a]anthracene (DMBA) in female adult rats were evaluated. Administration of modulators was carried out from the age of 40±3 days to 240±3 days. When DMBA alone was given 100% of the rats developed mammary tumors. When modulators were given singly the tumor incidences were reduced to 51.77% (SS), 46.4% (MC), 57.1% (AA) and 48.1% (RA). When the modulators were given in combination of twos, the tumor incidences were further reduced to 29.5% (SS + MC), 31% (SS + AA), 29.6% (SS + RA), 25.9% (MC + AA), 31.8% (MC + RA) and 34.6% (AA + RA). Administration of modulators in combinations of threes resulted in still further reduction of tumor incidences to 22.2% (SS + MC + AA), 19.2% (SS + MC + RA), 16% (MC + AA + RA) and 23.1% (AA + RA + SS). When all four modulators were given concurrently the tumor incidence was only 12%. Further, the number of tumors per tumor‐bearing animal declined with the increase in the number of agents used in combination for modulation.
机译:亚硒酸钠(SS),氯化镁(MC),抗坏血酸(AA)和乙酸视黄酯(RA)的化学预防作用,单独或组合使用对30 mg 7,12-二甲基苯[a]诱导的乳腺癌致癌作用。对雌性成年大鼠的蒽(DMBA)进行了评估。从40±3天至240±3天的年龄进行调节剂的施用。仅给予DMBA时,100%的大鼠会患上乳腺肿瘤。单独使用调节剂时,肿瘤发生率降低到51.77%(SS),46.4%(MC),57.1%(AA)和48.1%(RA)。当组合使用调节剂时,肿瘤发生率进一步降低至29.5%(SS + MC),31%(SS + AA),29.6%(SS + RA),25.9%(MC + AA),31.8 %(MC + RA)和34.6%(AA + RA)。三者组合使用调节剂可使肿瘤发生率进一步降低至22.2%(SS + MC + AA),19.2%(SS + MC + RA),16%(MC + AA + RA)和23.1%(AA) + RA + SS)。同时使用所有四种调节剂时,肿瘤发生率仅为12%。此外,随着用于调制的联合用药数量的增加,每只荷瘤动物的肿瘤数量下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号